IRIS
PRINCIPI, MARIABEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.019
AS - Asia 3.743
EU - Europa 2.396
SA - Sud America 1.064
AF - Africa 142
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.881
SG - Singapore 1.489
BR - Brasile 824
CN - Cina 823
HK - Hong Kong 481
SE - Svezia 440
RU - Federazione Russa 414
IT - Italia 339
VN - Vietnam 314
DE - Germania 312
FR - Francia 197
GB - Regno Unito 193
FI - Finlandia 164
IN - India 112
BD - Bangladesh 93
UA - Ucraina 80
AR - Argentina 78
ID - Indonesia 65
IQ - Iraq 62
CA - Canada 57
BE - Belgio 54
MX - Messico 47
TR - Turchia 46
ZA - Sudafrica 46
PL - Polonia 40
CO - Colombia 39
PK - Pakistan 38
EC - Ecuador 32
NL - Olanda 31
VE - Venezuela 31
JP - Giappone 28
ES - Italia 27
UZ - Uzbekistan 26
SA - Arabia Saudita 25
RO - Romania 21
CL - Cile 20
PH - Filippine 20
MA - Marocco 17
IE - Irlanda 16
CI - Costa d'Avorio 15
AE - Emirati Arabi Uniti 14
AL - Albania 14
DZ - Algeria 13
EG - Egitto 13
MY - Malesia 13
PY - Paraguay 13
TN - Tunisia 13
AU - Australia 12
PE - Perù 12
AT - Austria 11
AZ - Azerbaigian 11
KE - Kenya 11
GT - Guatemala 9
IL - Israele 8
KR - Corea 8
KZ - Kazakistan 8
LB - Libano 8
UY - Uruguay 8
NP - Nepal 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
JO - Giordania 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
EU - Europa 5
LT - Lituania 5
CR - Costa Rica 4
HN - Honduras 4
JM - Giamaica 4
KG - Kirghizistan 4
MK - Macedonia 4
PA - Panama 4
PS - Palestinian Territory 4
QA - Qatar 4
CH - Svizzera 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
LV - Lettonia 3
OM - Oman 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
EE - Estonia 2
FJ - Figi 2
GE - Georgia 2
IR - Iran 2
KW - Kuwait 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
Totale 17.369
Salva come PNG Salva come JPEG
Città #
Fairfield 1.284
Ashburn 999
Woodbridge 918
Singapore 796
Chandler 680
Houston 596
Seattle 508
Hong Kong 478
Cambridge 464
San Jose 433
Wilmington 421
Ann Arbor 420
Nyköping 361
Beijing 285
Dallas 226
Jacksonville 221
New York 167
Lawrence 132
Roxbury 130
Nanjing 125
Lauterbourg 116
Los Angeles 110
Council Bluffs 101
Ho Chi Minh City 101
Des Moines 79
Bari 77
Helsinki 76
São Paulo 72
Princeton 71
Inglewood 68
Santa Clara 59
Brussels 53
Hanoi 53
Dearborn 52
Brooklyn 51
Boardman 50
San Diego 46
Jakarta 38
London 37
Munich 37
Chicago 36
Buffalo 35
Warsaw 35
Frankfurt am Main 32
The Dalles 28
Falkenstein 27
Shenyang 27
Dong Ket 26
Jiaxing 26
Rio de Janeiro 26
Atlanta 25
Tianjin 25
Columbus 24
Hebei 24
Nanchang 24
Montreal 23
Tokyo 23
Johannesburg 22
Paris 22
Tashkent 22
Orem 20
Baghdad 19
Changsha 19
Belo Horizonte 18
Moscow 18
Dhaka 17
Boston 16
Brasília 16
Dublin 16
Haiphong 16
Lahore 16
Medellín 16
Mexico City 16
Milan 16
Nuremberg 16
Abidjan 15
Chennai 15
Curitiba 15
Denver 15
Stockholm 15
Pune 14
Toronto 14
Ankara 13
Porto Alegre 13
Redwood City 13
Rome 13
Amsterdam 12
Da Nang 12
Guangzhou 12
Poplar 12
Buenos Aires 11
Falls Church 11
San Francisco 11
Shanghai 11
Zhengzhou 11
Baku 10
Cape Town 10
Caracas 10
Mumbai 10
Nairobi 10
Totale 12.086
Salva come PNG Salva come JPEG
Nome #
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 219
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 204
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 195
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 195
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 195
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 191
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 185
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 184
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 182
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 181
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 180
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 179
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 169
A mysterious case of gastroparesis: could the secret be found in a drink? 165
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 165
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 162
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 154
Estrogens, phytoestrogens and colorectal neoproliferative lesions 151
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 150
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 147
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 146
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 145
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 144
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 142
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 138
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 138
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 137
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 135
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study 135
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 134
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 131
Celiac disease and common variable immunodeficiency: a familial inheritance? 131
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 129
Oral Tacrolimus (FK-506) in Crohn' s disease complicated by fistulae of perineum 128
Alimentary disorders in young females with irritable bowel syndrome or ulcerative procto-sigmoiditis: A preliminary report. 128
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 127
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 126
The PROSit cohort of infliximab biosimilar in IBD: A prolonged follow-up on the effectiveness and safety across Italy 126
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 126
The association between cardiac and gastrointestinal disorders: causal or casual link? 125
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 125
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 122
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 121
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 121
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 115
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 113
The cost of inflammatory bowel disease management matches with clinical course: A single outpatient centre analysis 111
Pattern of apoptosis in Crohn’s disease: a singular aspect? 110
La qualità della vita dei pazienti affetti da infiammazione intestinale 108
Seronegative celiac disease: where is the specific setting? 107
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 106
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 103
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 103
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 103
Lactobacillus reuteri strain combination in helicobacter pylori infection: A randomized, double-blind, placebo-controlled study 102
null 101
Effect of Helicobacter Pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression 101
Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis. 100
null 100
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study 100
Liver fibrosis in primary intestinal lymphangiectasia: an undervalued topic 99
La gastrite cronica da Helicobacter Heilmannii: una nuova entità istopatologica. L’ infezione da Helicobacter pilori: aggiornamento continuo G Bianchi Porro, G Maconi, F Parente 99
null 99
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 99
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data] 95
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 95
null 94
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 93
Appliance of immunohistochemical techniques in Helicobacter pylori infection. Immunohistochemistry and Helicobacter pylori 91
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 91
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 91
null 90
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 90
null 89
Differential immunohistochemical expression of Syndecan-1 and Tumor necrosis factor alpha in colonic mucosa of patients with Crohn’s disease 89
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 89
Mucosal expression of Basic Fibroblastic Growth Factor, Syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies 88
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase 88
Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? 87
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 87
Probiotics and Helicobacter pylori 86
null 86
null 86
Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis 86
null 85
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity—authors’ reply 85
Liver involvement in inflammatory bowel disease: What should the clinician know? 84
Lupus nephritis improvement after anti-tumor necrosis factor alpha monoclonal antibody (infliximab) treatment for Crohn disease: a case report 84
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 84
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 84
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 84
Immunosuppressant supplementation to infliximab in Crohn's disease with extraintestinal involvement: A benefit in the long term? 83
New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study 83
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? 83
null 82
Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: A preliminary report. 82
Long-term tacrolimus: a promising therapeutic approach for Crohn’s disease 82
null 81
null 81
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 81
Totale 11.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021427 0 0 0 0 0 0 0 0 0 227 84 116
2021/20221.029 101 44 37 37 54 101 27 55 61 90 166 256
2022/20231.688 241 235 124 140 154 239 23 184 261 12 47 28
2023/2024566 35 107 23 55 52 163 14 22 6 27 13 49
2024/20252.524 40 36 161 76 57 218 337 234 107 144 398 716
2025/20265.553 882 352 434 632 729 320 620 196 823 565 0 0
Totale 18.051